Background: According to a recent survey, Poland is one of the leaders of interventional cardiology in Europe in terms of the number of primary percutaneous coronary intervention (PCI) procedures per million inhabitants.
INTRODUCTION
Guidelines from the European Society of Cardiology (ESC) advocate quality control for revascularisation procedures [1] .
Only high-quality long-term registries of consecutive patients may provide adequate control over the whole spectrum of percutaneous coronary interventions (PCI) in invasive cardiology centres. Multiple high-number international registries have researched outcomes mainly in patients with acute coronary syndromes [2] [3] [4] . It seems, however, that a more tailored approach for local assessment is required since regional differences still exist even though the "Stent for Life" initiative has been widely promoted across ESC member states [3, 5, 6] .
National registries like SWEDEHEART, PL-ACS, AMIS, and MITRA provide answers adequate for local conditions and demographics [7] [8] [9] [10] .
According to a recent survey, Poland is one of the leaders of interventional cardiology in Europe in terms of the number of primary PCI procedures per million inhabitants [5] . This has been the main trigger to analyse Polish data separately. In Poland, there are currently two ongoing national registries: PL-ACS (including the whole spectrum of acute coronary syndrome patients both treated invasively and non-invasively) and the Polish National PCI Registry (only patients treated with percutaneous interventions) [8] . Annual reports from the latter are published each year by the Polish Association of Cardiovascular Interventions of the Polish Cardiac Society [11, 12] .
The aim of this study is to present temporal trends and patterns in epidemiology, demographics, treatment, and periprocedural outcome of patients referred for percutaneous coronary angiography and angioplasty in Poland in 2005-2011, based on the Polish National PCI Registry. Patients who underwent percutaneous coronary angiography (ANGIO group) and/or angioplasty (PCI group) were included in the registry. Data on demographics, past medical history, and clinical status were analysed. Only periprocedural outcome and procedural success were reported. The data in the registry were not validated by independent monitors or institutions, nor were they checked for consistency with source data documentation. They are based on the input provided from participating centres to the database. The registry protocol complied with the Declaration of Helsinki (with later amendments). Table 2 . (Fig. 1) . Numbers split by years are presented in Tables 1 and 2 and graphically in Figure 1 . The PCI to ANGIO ratio as well as percentage of PCI in acute coronary syndrome (ACS) cases is also presented in Figure 1 . Baseline demographics for ANGIO and PCI groups stratified by year are presented in Tables 1 and 2 . Periprocedural outcome for ANGIO and PCI groups is depicted in Tables 3 and 4 . Drug eluting stent (DES) utilisation and radial access site usage among ST elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), unstable angina, and stable angina patients is presented in Figures 2 and 3 . CABG -coronary artery bypass graft; MI -myocardial infarction; reMI -repeated myocardial infarction DISCUSSION The current paper summarises temporal trends and patterns in the invasive treatment of coronary artery disease in Poland based on the National PCI Registry. Since 2005 there has been a year-by-year straight significant trend towards higher numbers of PCI and angiography procedures being performed in Poland. Detailed reporting of invasive procedures in all active invasive cardiology centres and managed at a national level by Polish Cardiac Society allowed to gather data on almost 1.5 million catheterisations and PCIs over a period of seven calendar years (2005) (2006) (2007) (2008) (2009) (2010) (2011) . At the same time, the number of catheterisation labs, which are scattered and equally distributed around the country, increased almost by 100% [6, 13] . In 2012, according to the annual report, there was one cathlab per 256,000 inhabitants, which is still well in line with ESC STEMI guidelines [12, 14] . It is noticeable in the Polish registry that the population treated with interventional procedures is becoming older, and the proportion of women has also increased over the years. At the same time, the number of comorbidities that mostly influence coronary artery disease, like diabetes and chronic kidney disease, has risen since 2005. In other words, patient with higher risk are being approached, which surprisingly does not translate into poorer outcome of coronary angiography itself. It is interesting to see that the number of coronary angiographies that report no significant atherosclerotic changes that would require revascularisation of any sort is stable over the years and was reported in 1/3 of patients. That allowed us to admit that the selection and qualification of patients for invasive diagnostics are still appropriate, and the increasing number of cathlabs and procedures is not associated with poorer quality of these procedures. This is basically confirmed when looking at the numbers describing periprocedural outcome, which has remained the same in terms of death, urgent coronary artery bypass grafting, myocardial infarction, and stroke throughout the years and is fairly low in comparison to other registries.
METHODS

Statistical methods
The situation for the PCI subgroup in terms of survival is slightly different. A significant trend in mortality (from 0.44% in 2005 to 0.79% in 2011) has been noticed. However, one has to take into account the changing demographics. In 2011 vs. 2005 patients referred for PCI were ca. two years older and more frequently with hypertension, diabetes, prior stroke, and chronic kidney disease, which may have triggered higher mortality rates. Even though the number of cases of STEMI treated with PCI has risen in terms of absolute numbers from 2005 to 2011, the overall percentage has decreased mainly in favour of unstable angina, which was more frequently diagnosed. This is similar to German data, in which NSTEMI patients were markedly increased in numbers from 2005 to 2009 [15] . Moreover, as many as 2/3 of all PCIs were performed in 2011 in patients with an ACS, which is a significant increase from 57% in 2005. The use of DES is more frequent in patients with stable angina; however, a trend from 6% in 2005 to 38.2% in 2011 has been observed in the overall PCI population (over 55% in stable angina patients). The utilisation of glycoprotein IIb/IIIa inhibitors is small and a diversion from abciximab to integrillin has been observed. Polish operators are also in line with recent trials and have adopted the radial approach as a preferred one not only in elective cases (over 39% in 2011) but also in a STEMI setting (a 10% absolute increase in two years). Thrombectomy was used in 1 in 5 STEMI patients in 2011.
It seems that a well planned development of interventional cardiology at a scientific and governmental level in Poland has resulted in fulfilling major ESC guideline requirements and the "Stent for Life" initiative aims in a relatively short time [5] .
Limitations of the study
The data in the registry including major adverse cardiovascular events were not validated and checked against source documentation. We were also unable to provide follow-up information and long-term outcome of patients.
CONCLUSIONS
The progress of Polish interventional cardiology from 2005 till 2011 is significant in terms of absolute number of angiography and PCI procedures as well as the number of active cathlab centres. Use of modern attributes of interventional cardiology like DES stents, radial approach, and treatment of higher risk patients has been increasing over the years. The numbers of periprocedural life-threatening complications are low and stable in occurrence in patients undergoing coronary angiography. The adoption of the "Stent for Life" initiative has resulted in an increasing number of percutaneous coronary procedures over the years.
